Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-08-10 Sale | 2023-08-11 4:48 pm | Aceragen Inc. | ACGN | GOWEN MAXINE Director | 51 | $0.51 | $26 | 0 (Indirect) | View |
| 2020-06-08 Sale | 2020-06-09 4:17 pm | Akebia Therapeutics Inc. | AKBA | GOWEN MAXINE Director | 4,567 | $12.05 | $55,032 | 44,233 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-06 Option Award | 2024-06-10 4:15 pm | N/A 2034-06-05 | Aclaris Therapeutics Inc. | ACRS | GOWEN MAXINE Director | 20,543 | $0 | 20,543 (Direct) | View |
| 2024-06-01 Exercise | 2024-06-04 4:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | GOWEN MAXINE Director | 4,660 | $0 | 16,961 (Direct) | View |
| 2024-05-21 Option Award | 2024-05-23 4:56 pm | N/A 2034-05-21 | Passage BIO Inc. | PASG | GOWEN MAXINE Director | 47,693 | $0 | 47,693 (Direct) | View |
| 2024-05-07 Option Award | 2024-05-09 4:30 pm | N/A 2034-05-07 | Merus N.V. | MRUS | GOWEN MAXINE Director | 8,844 | $0 | 8,844 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:15 pm | N/A 2033-06-08 | Merus N.V. | MRUS | GOWEN MAXINE Director | 14,414 | $0 | 14,414 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 5:04 pm | N/A 2033-05-31 | Aclaris Therapeutics Inc. | ACRS | GOWEN MAXINE Director | 20,410 | $0 | 32,711 (Direct) | View |
| 2023-06-02 Exercise | 2023-06-05 5:04 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | GOWEN MAXINE Director | 4,507 | $0 | 32,711 (Direct) | View |
| 2023-05-25 Option Award | 2023-05-26 4:24 pm | N/A 2033-05-24 | Passage BIO Inc. | PASG | GOWEN MAXINE Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-27 4:31 pm | 2023-06-23 2032-06-23 | IDERA PHARMACEUTICALS INC. | IDRA | GOWEN MAXINE Director | 26,000 | $0 | 26,000 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-06 5:15 pm | N/A 2032-06-01 | Aclaris Therapeutics Inc. | ACRS | GOWEN MAXINE Director | 20,257 | $0 | 28,051 (Direct) | View |
| 2022-06-03 Exercise | 2022-06-06 5:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | GOWEN MAXINE Director | 3,356 | $0 | 28,051 (Direct) | View |
| 2022-05-31 Option Award | 2022-06-02 4:06 pm | N/A 2032-05-31 | Merus N.V. | MRUS | GOWEN MAXINE Director | 16,604 | $0 | 16,604 (Direct) | View |
| 2022-05-31 Option Award | 2022-06-01 4:27 pm | N/A 2032-05-30 | Passage BIO Inc. | PASG | GOWEN MAXINE Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-05-26 Option Award | 2022-05-31 4:22 pm | N/A 2032-05-25 | Passage BIO Inc. | PASG | GOWEN MAXINE Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2021-05-28 Option Award(A) | 2021-06-16 4:05 pm | N/A 2031-05-28 | Merus N.V. | MRUS | GOWEN MAXINE Director | 12,240 | $0 | 12,240 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-10 5:25 pm | 2022-06-08 2031-06-08 | IDERA PHARMACEUTICALS INC. | IDRA | GOWEN MAXINE Director | 26,000 | $0 | 26,000 (Direct) | View |
| 2021-06-03 Option Award | 2021-06-04 7:55 pm | N/A 2031-06-02 | Aclaris Therapeutics Inc. | ACRS | GOWEN MAXINE Director | 15,606 | $0 | 15,606 (Direct) | View |
| 2021-05-28 Option Award | 2021-06-02 4:10 pm | N/A 2031-05-28 | Merus N.V. | MRUS | GOWEN MAXINE Director | 12,240 | $0 | 12,240 (Direct) | View |
Ownership | 2021-06-02 4:05 pm | N/A 2030-10-23 | Merus N.V. | MRUS | GOWEN MAXINE Director | 0 | $0 | 7,957 (Direct) | View |
| 2021-05-27 Option Award | 2021-06-01 1:51 pm | N/A 2031-05-26 | Passage BIO Inc. | PASG | GOWEN MAXINE Director | 4,542 | $0 | 4,542 (Direct) | View |
| 2021-02-18 Option Award | 2021-02-22 5:45 pm | N/A 2031-02-17 | Passage BIO Inc. | PASG | GOWEN MAXINE Director | 33,836 | $0 | 33,836 (Direct) | View |
| 2020-06-05 Option Award | 2020-06-09 4:17 pm | 2021-06-05 2030-06-05 | Akebia Therapeutics Inc. | AKBA | GOWEN MAXINE Director | 33,800 | $0 | 44,233 (Direct) | View |
| 2020-06-04 Option Award | 2020-06-08 5:45 pm | N/A 2030-06-03 | Aclaris Therapeutics Inc. | ACRS | GOWEN MAXINE Director | 16,500 | $0 | 16,500 (Direct) | View |
| 2020-05-12 Option Award | 2020-05-19 7:07 pm | 2021-05-12 2030-05-12 | IDERA PHARMACEUTICALS INC. | IDRA | GOWEN MAXINE Director | 11,500 | $0 | 11,500 (Direct) | View |
| 2020-05-13 Option Award | 2020-05-15 5:22 pm | N/A 2030-05-13 | TREVENA INC | TRVN | GOWEN MAXINE Director | 64,103 | $0 | 64,103 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 4:23 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | GOWEN MAXINE Director | 4,438 | $0 | 8,876 (Direct) | View |
| 2020-03-02 Exercise | 2020-03-04 4:23 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | GOWEN MAXINE Director | 4,438 | $0 | 8,876 (Direct) | View |